Categories: AntimicrobialNews

Microban International Wins Silver Edison Award for Sustainable Antimicrobial Technology Ascera™

HUNTERSVILLE, N.C., April 10, 2025 /PRNewswire/ — Microban International, the leader in antimicrobial solutions, has been awarded the silver Edison Award in the Materials Science category for its groundbreaking antimicrobial technology Ascera™. This prestigious honor, presented at the 2025 Edison Awards Gala in Fort Myers, Florida, on April 3, places Microban among an elite group of innovators recognized for their contributions to advancing technology and the industry.

Ascera is a patented metal-free antimicrobial technology inspired by nature. It is designed to inhibit bacterial growth by up to 99.99% while reducing environmental impact. Unlike traditional antimicrobials that rely on metal-based chemistries, Ascera’s active ingredient is similar to acids found in nature and has a long history of being used in multiple consumer product applications. Moreover, it provides UV-stable, 24/7 product protection and seamlessly integrates into polymers and coatings, extending product life and promoting sustainability. Ascera technology will soon also be available for use in textiles.

“We are honored to be recognized with the Edison Award for Ascera,” said Michael Ruby, president of Microban International. “This recognition highlights our commitment to pioneering sustainable ingredient technologies that enhance product durability while addressing environmental concerns. Ascera is part of our ongoing efforts to introduce a new generation of nature-inspired chemistries.”

The Edison Awards, named after Thomas Edison, celebrate the world’s top innovations, highlighting excellence in concept, value, delivery and impact. By securing a silver win, Microban joins the ranks of honorable innovators recognized for their significant contributions to materials science, further reinforcing its leadership in the field.

For more information about Ascera and Microban’s commitment to sustainable antimicrobial technology, visit www.microban.com.

About Microban International

Part of Barr Brands International, Microban International is home to the most trusted and well-known global brands in the antimicrobial, odor control and sanitization/disinfection markets: Microban® and Ultra-Fresh®. Our organization has experienced over 100 collective years of growth and has revolutionized the industry. As the global leader, our proactive systems keep products cleaner and control odors better by preventing problems before they start. Microban International drives innovation by combining science and creative solutions that enhance high-quality consumer, textile, industrial and medical products worldwide. Today, the Microban and Ultra-Fresh brands and our technologies are featured on thousands of products worldwide. The company is headquartered in North Carolina and operates in North America, Europe and Asia-Pacific. For more information, please visit www.microban.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/microban-international-wins-silver-edison-award-for-sustainable-antimicrobial-technology-ascera-302425157.html

SOURCE Microban International

Staff

Recent Posts

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

2 hours ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

5 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

5 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

5 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

5 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

5 hours ago